ARS Pharmaceuticals, Inc. SPRY Operating margin

Operating margin at other companies

Aquestive Therapeutics, Inc.AQST

-111.2%+96.3pp

Amneal Pharmaceuticals, Inc.AMRX

14.6%+1.4pp

ViatrisVTRS

-0.6%—

AMP

Amphastar PharmaceuticalsAMPH

15.7%-9.5pp

Neuropace, Inc.NPCE

-16.8%-3.5pp

Eton Pharmaceuticals, Inc.ETON

-15.1%—

FAQ

What is ARS Pharmaceuticals, Inc.'s operating margin?

ARS Pharmaceuticals, Inc. (SPRY) reported operating margin of -204.5% in Q1 2026.

What is the long-term trend for ARS Pharmaceuticals, Inc.'s operating margin?

Over 2 years (2022 to 2025), ARS Pharmaceuticals, Inc.'s operating margin has grown at a -71.9% compound annual growth rate (CAGR), from -2,698.8% to -212.9%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.